Biosimilar

定義

A biologic drug that is highly similar to an already approved reference biologic product, with no clinically meaningful differences in safety, purity, or potency. Unlike generics (which are chemically identical), biosimilars are structurally similar because biologics are too complex to replicate exactly.

関連用語

ガイドでの言及

• How Insulin and Diabetes Drugs Work
  Diabetes treatment encompasses a wide range of drugs — from insulin that replaces a missing hormone to newer agents that …
• Biosimilars vs. Generics
  Generics and biosimilars both offer lower-cost alternatives to brand-name drugs, but they work very differently. Understanding the distinction helps you …
• Complete Guide to Diabetes Medications
  An accessible overview of medications used for type 2 diabetes — from metformin to insulin — covering how each class …
• Complete Guide to Arthritis Medications
  A comprehensive guide to medications for osteoarthritis and rheumatoid arthritis — covering NSAIDs, DMARDs, biologics, biosimilars, and combination therapy strategies.
• Biosimilar Drugs: Affordable Biologics
  Biologics revolutionized treatment for cancer, autoimmune disease, and diabetes, but their cost can be prohibitive. Biosimilars offer comparable effectiveness at …
• The Future of Drug Pricing
  From the Inflation Reduction Act's Medicare negotiation authority to cell therapies priced at millions of dollars, the landscape of drug …
• GLP-1 Agonists: The Weight Loss Revolution
  GLP-1 receptor agonists like semaglutide and tirzepatide have redefined obesity treatment. Learn how they work, what the evidence shows, and …